Neuralink
Neural interfaces (connections between electronic devices and your brain), with the goal of being able to monitor your brain activity and eventually also be able to cure certain diseases
Analytics date: 27.11.2024
Basic information
Head office
Fremont, USHead officeGeography of business
United States of AmericaGeography of businessDate of the last round
Last round 11/2023Date of the last roundTotal funds raised
$847.7M+Total funds raisedPrice per share
$60.00Price per sharePrice per share. Based on the latest known transaction. It is not an offer or investment recommendation.
Analytics date: 27.11.2024
About Neuralink
Investment rounds
Basic Information
Logo | |
Legal name | © NEURALINK |
Industry | Healthcare engineering |
Specialization | Neuroscience |
Nature of ownership | Private |
Last round valuation | $3.5B |
Funds raised | $847.7M+ |
Key shareholders | Google Ventures, Valor Equity Partners |
Founded | 2016 |
Primary office | Fremont, US |
Geographical presence | United States of America |
Employees * https://pitchbook.com/profiles/company/179115-22#overview | 491 |
Founder | Elon Musk, Max Hodak |
Licenses | 05/2023 Approval from the US Food and Drugs Administration (FDA) to conduct tests on humans |
Key financial data
Employees | |
0000 000 | 000000 00 |
0000 | 0000000 00 |